CA
NZ
UK
AU
IND
US
Summit Therapeutics (NASDAQ:SMMT) is edging higher in Thursday's session after AstraZeneca (NYSE:AZN) agreed to invest $2 billion in its convertible preferred shares. The Miami-based oncology company is developing ivonescimab, a PD-1 and VEGF bispecific antibody in-licensed from China's Akeso, and shares are trading near …
Thermo Fisher Scientific (NYSE:TMO) is trading lower in Thursday's session, slipping to about $659 and underperforming a soft healthcare sector. No company-specific negative has been identified, which points to valuation and market conditions as the drivers.
United Therapeutics (NASDAQ:UTHR) is extending a powerful rally in Thursday's session after a federal court sided with the Silver Spring, Maryland-based rare disease company in its patent fight with Liquidia (NASDAQ:LQDA). The stock is trading near $583, up 7.57%, following a gain of roughly …
Zenas BioPharma (NASDAQ:ZBIO) is rebounding in Thursday's session, trading near $28.73 and recovering part of a roughly 9.7% decline over the past week. The Waltham, Massachusetts-based clinical-stage company develops immunology therapies for autoimmune disease, led by obexelimab, a bifunctional antibody targeting CD19 and FcγRIIb, …
Quantum-Si (NASDAQ:QSI) released interim development results on September 28, 2026 and presented them at the World HUPO Congress in Singapore on September 29. Chief executive Jeff Hawkins called Proteus a fundamentally superior platform rather than a bigger Platinum Pro and said the system is …
Apnimed (NASDAQ:APMD) priced its IPO at USD 16 on July 30, 2026 and began trading on theNasdaqGlobal Select Market on July 31. Its only clinical product is Oxnimbi, a once-daily oral pill combining aroxybutynin, an antimuscarinic, with atomoxetine, a norepinephrine reuptake inhibitor, intended to …
Inogen (NASDAQ:INGN) agreed to sell its U.S. oxygen rental division to Rotech Healthcare, a national home respiratory provider, under an asset purchase agreement. Rotech will acquire specified rentalAssetsfor estimated cash of up to USD 25 million, and the companies signed a separate long-termSupplyagreement under …
Autonomix Medical, Inc. (NASDAQ:AMIX) develops a catheter with a microchip sensing array that detects nerve signals from inside a blood vessel, with the aim of finding and treating overactive nerves that cause pain or high blood pressure. All of its candidates are Class II …
DataMeds AI, Inc. (NASDAQ:MEDS) had been in litigation with the sellers of Wellgistics, LLC, which it bought under an agreement dated May 11, 2023. The company had sued in Florida state court, and the sellers had sued in the Delaware Court of Chancery over …
Jaguar Health, Inc. (NASDAQ:JAGX) develops gastrointestinal drugs, including Mytesi for diarrhea in people with HIV. Under a privately negotiated exchange, it issued 481,584 shares to Streeterville Capital, LLC in return for a USD 3,400,000 cut in the balance of a secured note, while the …
Please wait processing your request...